A new DRUG TRIALS SNAPSHOT FOR EMPLICITI is now available. EMPLICITI is a drug used for the treatment of a form of blood cancer called multiple myeloma. It is for use in patients who have received one to three prior medications and is intended to be used in combination with another FDA-approved treatment for multiple myeloma called Revlimid (lenalidomide) and dexamethasone (a type of corticosteroid).
Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.
See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.
.png)
No hay comentarios:
Publicar un comentario